NCT01326221View on ClinicalTrials.gov

Single Dose Truvada in HIV-negative Men and Women

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Pharmacokinetic Study in Healthy Volunteers
Interventions
DRUG

tenofovir + emtricitabine

tenofovir 300mg + emtricitabine 200mg x one dose

Trial Locations (1)

27599

University of North Carolina, Chapel Hill

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER